News
  • Kyowa Hakko expands Setria® Glutathione brand in Europe

    Setria® is a branded form of glutathione and plays an important role including antioxidant protection, detoxification & immune system fortification...

  • AminoScope® Winter 2017

    The winter edition of AminoScope®, our global magazine to keep you abreast of important developments at Kyowa, is now available

  • The Spirit of Giving

    <p>It’s that special time of year again. Christmas is a period for good cheer, for giving presents to loved ones and those around us that we care about most. It's also a time to think of others who are less fortunate than we are.</p> <p>In this spirit of giving Kyowa Hakko Europe GmbH has made a donation to Unicef rather...

  • Thank you CPhI 2016!

    <p>Well that's CPhI over for another year! The world’s leading pharmaceutical outsourcing event took place at the beginning of this month in Barcelona. Months of planning and hard work and guess what? It all paid off!</p> <p>A hugely successful event held in one of the most beautiful cities in Europe, good weather, good food, beautiful architecture and best of all...

  • Aminoscope® Summer 2016

    <p> </p>

  • Publication on Citrulline in Journal of Novel Physiotherapies

    <p>KYOWA HAKKO BIO CO., LTD. (President and CEO: Chikakuni Kotani), published a research article titled ‘Effects of Citrulline<sup>*1</sup> Combined with Tadalafil<sup>*2</sup> on Monocrotaline-Induced Pulmonary Hypertension in Rats Compared with Arginine’ on Journal of Novel Physiotherapies.</p> <p><strong>Summary</strong><br /> Purpose: Tadalafil, phosphodiesterase5 (PDE5) inhibitor, was reported to have a therapeutic effect on pulmonary hypertension (PH) and citrulline is an amino acid to...

  • Poster presentation on L-Ornithine containing food at ESPEN 2015

    <p>KYOWA HAKKO BIO CO., LTD. (President and CEO: Chikakuni Kotani), will have a presentation titled ‘Long term supplementation with <small>L</small>-Ornithine*1 enriched nutrition in Japanese patients with pressure ulcer’ at <a href="http://www.espen.org/lisbon" target="_blank">ESPEN 2015.</a></p> <p>Date: September 6th, 2015<br /> Time: 9:00 a.m. - 18:00 p.m.<br /> Program number: SUN-PP175<br /> Place: The international Congress Centre of Lisbon (CCL)</p> <p><strong>Summary</strong><br /> Elderly...

  • Cognizin® Citicoline Presentation was held at Vitafoods Europe

    <p>An affiliate company of KYOWA HAKKO BIO CO., LTD. (President and CEO: Chikakuni Kotani), KYOWA HAKKO BIO ITALIA S.R.L. (Italia, Milan) held its presentation on "<a href="http://cognizin.com/" target="_blank">Cognizin</a>" during "Vitafoods Europe", the biggest health and functional food exhibition in Europe from 5th to 7th May in 2015. "<a href="http://cognizin.com/" target="_blank">Cognizin</a>" is Kyowa's brand name of Citicoline, a compound of Kyowa's...

  • Amino Acid Manufacturing Plant in Thailand completed

    <p>Tokyo, Japan, April 9, 2015 --- Kyowa Hakko Bio Co., Ltd. (Tokyo, Japan, CEO: Chikakuni Kotani, "Kyowa Hakko Bio") announced, THAI KYOWA BIOTECHNOLOGIES CO., LTD. (Rayong Province, Thailand, CEO: Akira Tsukihashi, "THAI KYOWA BIOTECHNOLOGIES"), a subsidiary of Kyowa Hakko Bio, has completed the construction of a new manufacturing plant for amino acids in Thailand.</p> <p>The market for amino acids has...

  • Change of the Company Name (trade name). DAIICHI FINE CHEMICAL CO., LTD. will become KYOWA PHARMA CHEMICAL CO., LTD.

    <p>Tokyo, Japan, March 16, 2015 --- DAIICHI FINE CHEMICAL CO., LTD. (President: Etsuo Ohshima, "DAIICHI FINE CHEMICAL"), a subsidiary of Kyowa Hakko Bio Co., Ltd. (President and CEO: Shuichi Ishino), will change its company name (trade name) to Kyowa Pharma Chemical Co., Ltd. Effective from October 1, 2015.</p> <p>The reason for the company name change is to bring imaged business...

Events

  • No upcoming Events